| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis
|
Bucher, Christoph
|
|
|
7 |
5 |
p. e364
|
artikel
|
| 2 |
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis – Authors' reply
|
Walker, Irwin
|
|
|
7 |
5 |
p. e364-e365
|
artikel
|
| 3 |
Advancement in monoclonal antibody therapy for multiple myeloma
|
Shigle, Terri Lynn
|
|
|
7 |
5 |
p. e354-e355
|
artikel
|
| 4 |
Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen?
|
D'Agostino, Mattia
|
|
|
7 |
5 |
p. e355-e357
|
artikel
|
| 5 |
Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review
|
Smith, Ellen M Lavoie
|
|
|
7 |
5 |
p. e408-e417
|
artikel
|
| 6 |
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
|
Wang, Tao
|
|
|
7 |
5 |
p. e362-e363
|
artikel
|
| 7 |
Clinical trial material
|
Costa, Luciano J
|
|
|
7 |
5 |
p. e368
|
artikel
|
| 8 |
Handling the COVID-19 pandemic in the oncological setting
|
Mussetti, Alberto
|
|
|
7 |
5 |
p. e365-e366
|
artikel
|
| 9 |
Is there a role for new drugs with alkylating properties in multiple myeloma?
|
Mateos, María-Victoria
|
|
|
7 |
5 |
p. e357-e359
|
artikel
|
| 10 |
Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1–2 study
|
Richardson, Paul G
|
|
|
7 |
5 |
p. e395-e407
|
artikel
|
| 11 |
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial
|
Raab, Marc S
|
|
|
7 |
5 |
p. e381-e394
|
artikel
|
| 12 |
Patients with haematological malignancies should not have to choose between transfusions and hospice care
|
Odejide, Oreofe O
|
|
|
7 |
5 |
p. e418-e424
|
artikel
|
| 13 |
Shaping cancer policy to work towards the interests of patients
|
Burki, Talha K
|
|
|
7 |
5 |
p. e369
|
artikel
|
| 14 |
Strategic plan for management of COVID-19 in paediatric haematology and oncology departments
|
He, Yulei
|
|
|
7 |
5 |
p. e359-e362
|
artikel
|
| 15 |
Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial
|
Mateos, Maria-Victoria
|
|
|
7 |
5 |
p. e370-e380
|
artikel
|
| 16 |
The resurgence of convalescent plasma therapy
|
The Lancet Haematology,
|
|
|
7 |
5 |
p. e353
|
artikel
|
| 17 |
Transgender health and haematology—a matter of respect
|
Connors, Jean M
|
|
|
7 |
5 |
p. e367
|
artikel
|
Tijdschrift beschrijving